Increased hematocrit and reduced blood pressure following control of glycemia in diabetes

Clinical Hemorheology and Microcirculation

Volumn 38, Issue 1, 2008, Pages 67-74

  Salazar Vázquez, Beatriz Y ^a,b   Salazar Vázquez, Miguel A ^a   Venzor, Verónica Covarrubias ^c   Negrete, Adolfo Chávez ^c   Cabrales, Pedro ^d   Díaz, Jesús Sida ^c   Intaglietta, Marcos ^b  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^d LA JOLLA BIOENGINEERING INSTITUTE   (United States)

Author keywords

Blood pressure; Blood viscosity; Diabetes treatment; Glycemic control; Hematocrit; Kidney function; Nitric oxide

Indexed keywords

CHOLESTEROL; CREATININE; GLIBENCLAMIDE; GLUCOSE; METFORMIN; TRIACYLGLYCEROL;

ARTERIAL PRESSURE; ARTICLE; BIOAVAILABILITY; BLOOD VISCOSITY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIET THERAPY; EXERCISE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMATOCRIT; HUMAN; KIDNEY FUNCTION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SHEAR STRESS; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR RESISTANCE; VASODILATATION;

EID: 37149056224     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure, Arch. Intern. Med. 157 (1997), 2413-2446.
2. O.K. Baskurt et al., Blood rheology and hemodynamics, Semin. Thromb. Hemost. 29 (2003), 435-450.
3. A.E. Caballero et al., Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes, Diabetes 48 (1999), 1856-1862.
4. G. Charpentier et al., Improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients, Diabet. Med. 18 (2001), 828-834.
5. L.G. de Aguiar et al., Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance, Diabetes Care 29 (2006), 1083-1089.
6. G. de Simone et al., Association of blood pressure with blood viscosity in American Indians: The Strong Heart Study, Hypertension 45 (2005), 625-630.
7. P.G. Fegan et al., Capillary pressure in subjects with type 2 diabetes and hypertension and the effect of antihypertensive therapy, Hypertension 41 (2003), 1111-1117.
8. D.R. Gagnon et al., Hematocrit and the risk of cardiovascular disease - the Framingham study: A 34-year follow-up, Am. Heart. J. 127 (1994), 674-682.
9. M. González-Ortiz et al., Effectiveness and security of the combined oral hipoglucemiante therapy of glimepirida more metformina in a single pharmaceutical form in patients with type 2 diabetes mellitus and fails secondary to glibenclamida monotherapy with glibenclamide [Eficacia y seguridad de la terapia hipoglucemiante oral combinada de glimepirida más metformina en una sola forma farmacéutica en pacientes con diabetes mellitus tipo 2 y falla secundaria a monoterapia con glibenclamida], Rev. Invest. Clin. 56 (2004), 327-333.
10. M.V. Kameneva et al., Gender difference in rheologic properties of blood and risk of cardiovascular diseases, Clin. Hemorheol. Microcirc. 21 (1999), 357-363.
11. J. Martini et al., Paradoxical hypotension following increased hematocrit and blood viscosity, Am. J. Physiol. Heart Circ. Physiol. 289 (2005), H2136-H2143.
12. K. Nellore et al., Nitric oxide measurements in rat mesentery reveal disrupted venulo-arteriolar communication in diabetes, Microcirculation 11 (2004), 415-423.
13. Y. Oyama et al., Attenuation of endothelium-dependent relaxation in aorta from diabetic rats, Eur. J. Pharmacol. 132 (1986), 75-78.
14. J. Pleiner et al., FFA-induced endothelial dysfunction can be corrected by vitamin C, J. Clin. Endocrinol. Metab. 87 (2002), 2913-2917.
15. W.H. Reinhart et al., Influence of blood withdrawal and anticoagulant on clotting activity, hematologic data, and certain rheologic measurements, J. Lab. Clin. Med. 115 (1990), 98-103.
16. I. Saenz de Tejada et al., Impaired neurogenic and endothelium-mediated relaxation of penile smooth muscle from diabetic men with impotence, N. Engl. J. Med. 320 (1989), 1025-1030.
17. B.Y. Salazar-Vazquez et al., Blood pressure and hematocrit in diabetes and the role of endothelial responses in the variability of blood viscosity, Diabetes Care 29 (2006), 1523-1528.
18. J.R. Singleton et al., Microvascular complications of impaired glucose tolerance, Diabetes 52 (2003), 2867-2873.
19. T. Somer et al., Disorders of blood viscosity, Ann. Med. 25 (1993), 31-39.
20. M.C. Thomas et al., The burden of anaemia in type 2 diabetes and the role of nephropathy: A cross-sectional audit, Nephrol. Dial. Transplant. 19 (2004), 1792-1797.
21. J.E. Tooke et al., Microvascular functional abnormalities in diabetes: The role of the endothelium, Diabetes Res. Clin. Pract. 31 (Suppl.) (1996), S127-S132.